𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously Treated Non–Small-Cell Lung Cancer

✍ Scribed by Alexander I. Spira; Nicholas O. Iannotti; Michael A. Savin; Marcus Neubauer; Nashat Y. Gabrail; Ronald H. Yanagihara; Edith A. Zang; Patricia E. Cole; Dale Shuster; Asha Das


Book ID
113544776
Publisher
CIG Media Group, LP.
Year
2012
Tongue
English
Weight
350 KB
Volume
13
Category
Article
ISSN
1525-7304

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES